Share Twitter LinkedIn Facebook Email Dr. Hiral D. Parekh, M.D. discusses Cost Analysis of an Initial Observation Approach in Metastatic Renal Cell Carcinoma at the Kidney Cancer meeting in Chicago
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read